Odyssey Therapeutics Appoints Timothy P. Walbert and Ian F. Smith to Board of Directors
Key Highlights Timothy P. Walbert: Former Chairman, President & CEO of Horizon Therapeutics, instrumental in $28.3 billion acquisition…
Browsing Tag
Jeff Leiden
2 posts
Odyssey Therapeutics Secures $101 Million in Series C Funding to Propel Immunomodulators and Oncology Medicines
Key Highlights Odyssey Therapeutics, Inc. completes a significant $101 million Series C financing round led by Ascenta Capital. The funding will…